PRKN and myeloid sarcoma: Several cases of co-occurrence of PD after the diagnosis of MS have been reported [28], including a patient with early-onset Parkinson’s disease and a heterozygous PARK2 mutation who, after 8 years, developed primary progressive MS [29].